Legal Terms and Conditions for Using this Website

Thank you for visiting the Website (the “Site”) of Laureate Pharma, Inc. (“Laureate Pharma”). Any user who accesses all or any part of this Site agrees that such user is at least eighteen (18) years old and that such user has consented to these Legal Terms and Conditions For Using This Website and the Privacy Policy of Laureate Pharma. Each time a user accesses our Site, our policies should be reviewed because we reserve the right to change them from time to time.

I. COPYRIGHT AND TRADEMARK NOTICE

The entire content of this Site is fully protected under all applicable copyright and trademark laws. Users may print a single copy of the content of this Site for their personal noncommercial use only. Further printing, copying, redistribution or publication of any part of this Site is strictly prohibited unless expressly permitted within.

II. RESTRICTIONS ON USING THE CONTENT OF THIS SITE

The Site contains information about products and services that may or may not be available in a particular country or region of the world, may be available under different trademarks in different countries and, where applicable, may be approved by government regulatory authority for sale or use with different indications and restrictions in different countries.

This Site may contain, from time to time, information related to various health, medical and fitness conditions and their treatment. For non-healthcare providers, such information is not intended to be a substitute for the advice provided by a physician or other medical professional. You should not use the information contained herein for diagnosing a health or fitness problem or disease. In any event, users of this Site should always consult a doctor and/or other medical professional with respect to health concerns.

While Laureate Pharma uses reasonable efforts to include accurate and up-to-date information in its Site, Laureate Pharma makes no warranties or representations as to its accuracy. Laureate Pharma assumes no liability or responsibility for any errors or omissions in the content of its Site.

III. USER SUBMISSIONS

If in the event the Site provides visitors with an opportunity to post messages, you shall not post or transmit any unlawful, threatening, libelous, defamatory, obscene, inflammatory, infringing, pornographic or profane material or material that could constitute or encourage conduct that would be considered a criminal offense, give rise to civil liability, or would otherwise violate the law. Laureate Pharma shall be free to disclose and use such submissions, without obligations whatsoever towards you, for any purpose and through any means.

IV. USE LIMITATIONS

You may not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, create derivative works from, transfer, or sell any information, software or services obtained from this Site without express written permission. You agree that you will not use any robot, spider, other automatic device or program, or manual process to monitor or copy this Site. You agree to not interfere or attempt to interfere with the proper operation of this Site, including through the use of any device, software or routine.

As a condition of your use of this Site, you warrant to Laureate Pharma that you will not use this Site for any purpose that is unlawful or prohibited by the terms, conditions and notices provided throughout this Site.

V. LIMITATION OF LIABILITY

Laureate Pharma provides the contents of its Site for informational purposes and for your general interest and entertainment only. Under no circumstances shall Laureate Pharma be liable for your reliance on any such information nor shall Laureate Pharma be liable for damages of any kind, including, without limitation, any direct, incidental, special, indirect, punitive or consequential damages (including, but not limited to, loss of profit, lost data or information, loss of use of this Site, business interruption, loss of business reputation or goodwill, costs of substitute services, or downtime costs) which any third party may incur or experience, arising out of or relating to the use of, or the inability to use, the materials in this Site or the materials in any Site which may be linked to this Site, even if Laureate Pharma or a Laureate Pharma authorized representative has been advised of the possibility of such damages and notwithstanding any failure of essential purpose of any limited remedy. Applicable law may not allow the limitation or exclusion of liability or incidental or consequential damages, so the above limitation or exclusion may not apply to you. In no event shall Laureate Pharma’s total liability to you for all damages, losses, and causes of action whether the cause of action is in contract, tort (including, but not limited to, negligence) or otherwise exceed the amount paid by you, if any, for accessing this Site.

VI. DISCLAIMER OF WARRANTIES

THE SITE AND THE MATERIALS IN THIS SITE ARE PROVIDED “AS IS”. LAUREATE PHARMA DISCLAIMS ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, OR THOSE WARRANTIES ARISING FROM A COURSE OF PERFORMANCE, A COURSE OF DEALING OR TRADE USAGE. LAUREATE PHARMA DOES NOT WARRANT THAT THE FUNCTIONS CONTAINED IN THE MATERIALS WILL BE UNINTERRUPTED OR ERROR-FREE, THAT DEFECTS WILL BE CORRECTED, OR THAT THIS SITE OR THE SERVER THAT MAKES IT AVAILABLE ARE FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS. LAUREATE PHARMA DOES NOT WARRANT OR MAKE ANY REPRESENTATIONS REGARDING THIS SITE, THE USE OR THE RESULTS OF THE USE OF THE MATERIALS IN THIS SITE IN TERMS OF THEIR ABILITY TO MEET YOUR REQUIREMENTS OR THEIR CORRECTNESS, ACCURACY, RELIABILITY, OR OTHERWISE. YOU (AND NOT LAUREATE PHARMA) ASSUME THE ENTIRE COST OF ALL NECESSARY SERVICING, REPAIR OR CORRECTION. APPLICABLE LAW MAY NOT ALLOW THE EXCLUSION OF IMPLIED WARRANTIES, SO THE ABOVE EXCLUSION MAY NOT APPLY TO YOU.

VII. ACCESS RESTRICTION

Laureate Pharma reserves the right to deny in its sole discretion any user access to this Site or any portion thereof without notice.

VIII. JURISDICTIONAL ISSUES/EXPORT RESTRICTIONS

This Site is controlled and operated by Laureate Pharma from its offices within the State of New Jersey, United States of America. Although the Internet is global in nature, the laws regulating the manner in which pharmaceutical companies convey medical or product information is not. Each country has its own set of rules, regulations and laws. As a result, information intended for dissemination in a particular country may not be appropriate for use outside that country. The information on this Site is designed to comply with the laws of the United States. The information on this Site is intended for access and use by U.S. residents only. This Agreement shall be governed by and construed in accordance with the laws of the State of New Jersey, without giving effect to any principles of conflicts of law. Laureate Pharma and each user submits to the exclusive jurisdiction of, the state and federal courts located in the State of New Jersey, and waives any jurisdictional, venue, or inconvenient forum objections to such courts. If any provision of this Agreement shall be unlawful, void, or for any reason unenforceable, then that provision shall be deemed severable from this Agreement and shall not affect the validity and enforceability of any remaining provisions. This is the entire Agreement between the parties relating to the subject matter herein.

This Site may link to other Sites produced by companies related to Laureate Pharma, some of which are outside the U.S. Those Sites may have information that is appropriate only to the particular originating country or region where the Site is based. You should not construe anything on the Site as a promotion or solicitation for any product or for the use of any product that is not authorized by the laws and regulations of the country where you are located. Laureate Pharma makes no representation that materials in the Site are appropriate or available for use in other locations. Those who choose to access this Site from other locations do so on their own initiative and are responsible for compliance with local laws, if and to the extent local laws are applicable.

Software from this Site is further subject to United States export controls. No software from this Site may be downloaded or otherwise exported or reexported (i) into (or to a national or resident of) Cuba, Iraq, Libya, North Korea, Iran, Syria or any other country subject to United States export control restrictions; or (ii) to anyone on the U.S. Treasury Department’s list of Specially Designated Nationals or the U.S. Commerce Department’s Table of Denial Orders. By downloading or using the Software, you represent and warrant that you are not located in, under the control of, or a national or resident of any such country or on any such list.

IX. CAREER OPPORTUNITIES

The Site displays information about job postings (“Current Openings”) for informational purposes only. This information is subject to change without notice, and in displaying such information, Laureate Pharma makes no representation or warranty that the information contained on the Site will be timely or free of errors and omissions.

It is the intent of Laureate Pharma to leave you with absolute control over the decision to forward your personal information or resume to the company. It is your choice to give Laureate Pharma your personal information via the Internet, Fax or Mail.

Under no circumstances, should you use this Site or any of the fax and mailing addresses on the web site to send Laureate Pharma confidential or proprietary information. Laureate Pharma does not want to receive such confidential or proprietary information. Data which is not personal, including questions, comments, ideas, and suggestions shall be deemed to be non-confidential, and Laureate Pharma shall be free to disclose and use the same, without obligations whatsoever towards you, for any purpose and through any means.

Although accessible by others, the intent of Laureate Pharma in displaying Current Openings on this Site is to display employment opportunities within the United States of America. You should not construe anything on the Site as a promotion or solicitation for employment not authorized by the laws and regulations of the country where you are located.

X. LINKING POLICY

Links Out — This Site may provide links or references to other Websites not affiliated with Laureate Pharma. Laureate Pharma has not reviewed the content of Websites that may be linked to its Site, makes no representations about the content of the Websites, and is not responsible for the content of any other Website linked to this Site. Linking to any pages off this Site is at your own risk. Laureate Pharma shall not be liable for any damages or injury arising from users’ access to such Websites.

Links In — Unless otherwise set forth in a written agreement between you and Laureate Pharma, you must adhere to Laureate Pharma’s linking policy as follows: i) any link to a Laureate Pharma Site must be a text only link clearly marked “Laureate Pharma Web Site”, ii) the appearance, position and other aspects of the link may not be such as to damage or dilute the goodwill associated with Laureate Pharma’s name or trademarks, iii) the link must point to the specific URL listed below:

www.laureatepharma.com

and not to other pages within the website, iv) the appearance, position and other attributes of the link may not create the false appearance that your organization or entity is sponsored by, associated with, or affiliated with Laureate Pharma or the Site, v) when selected by the user, the link must display the Website on full screen and not within a “frame” on the linking Website, and vi) the linked Website must comply with all applicable U.S. laws, rules, and regulations.

Pharmacy News

Laureate and ARIUS Cooperation

Princeton, NJ and Paris, France, March 27, 2008: Laureate Pharma, Inc., a full-function facility of biopharmaceutical development and protein manufacturing, claimed nowadays that it has signed a contract with Cytheris SA, a clinical phase of biopharmaceutical facility oriented on trials and development of new treatment for immune stimulation. According to the contract, Laureate will produce Cytheris’ lead product candidate, Interleukin-7 (IL-7), a complete glycated recombinant human protein and crucial growth-stimulating…

Laureate Announces Second Manufacturing Agreement with Cytheris

Princeton, NJ and Paris, France, March 27, 2008: Laureate Pharma, Inc., a full-function facility of biopharmaceutical development and protein manufacturing, claimed nowadays that it has signed a contract with Cytheris SA, a clinical phase of biopharmaceutical facility oriented on trials and development of new treatment for immune stimulation. According to the contract, Laureate will produce Cytheris’ lead product candidate, Interleukin-7 (IL-7), a complete glycated recombinant human protein and crucial growth-stimulating factor for…

Laureate Pharma Agreement with Alopexx Pharmaceuticals

Laureate To Manufacture Alopexx’s Product Candidate On April 10, 2008, Laureate Pharma, Inc., a large company engaged in biopharmaceutical development and protein production reported that it has concluded a contract manufacturing agreement with Alopexx Pharmaceuticals on the production of Alopexx’s mAb F598 antibody under cGMP conditions. This antibody will be used in clinical trials and also for fighting Staphylococcus aureus infections. The details of the agreement were not announced. “We are happy that Laureate…

Laureate Pharma Company – Press Release

FOR IMMEDIATE RELEASE Laureate Pharma Launches New Contract Manufacturing Venture Company offers services for development and manufacture of biopharmaceuticals and sustained-release products Princeton, NJ – May 21, 2002 – Laureate Pharma Company announces the launch of contract manufacturing services at its two sites in New Jersey. Biopharmaceutical development and manufacturing services will be provided at a cGMP manufacturing facility in Princeton, NJ. Services related to sustained release microsphere products will…

Laureate Pharma Extends its Agreement with Cytogen for Manufacture of PROSTASCINT®

Princeton, NJ – October 25, 2006: Laureate Pharma, Inc. announced today that it has renewed its agreement with Cytogen Corporation for the cGMP manufacture of ProstaScint®, Cytogen’s proprietary monoclonal antibody immunoconjugate that is used for imaging in patients diagnosed with prostate cancer. Under the agreement, Laureate will provide cGMP protein production, purification, conjugation of Cytogen’s proprietary linker chelator and aseptic filling services to support Cytogen’s commercial ProstaScint® requirements. Terms of…

Laureate Pharma & DrugAbuse Sciences – Press Release

FOR IMMEDIATE RELEASE Laureate Pharma and DrugAbuse Sciences Announce Commercial Manufacturing Services Agreement. Princeton, NJ – June 24, 2002 – Laureate Pharma L.P. and DrugAbuse Sciences, Inc. announce the initiation of a contract manufacturing agreement related to a sustained release microsphere product. Under the agreement, Laureate Pharma will provide manufacturing services for DrugAbuse Sciences’ Naltrexone Depot product, currently in clinical trials. Terms of the agreement were not disclosed. “We are…

LAUREATE PHARMA COMPLETES SALE OF TOTOWA, NJ OPERATIONS TO DISCOVERY LABORATORIES FOR $16.0 MILLION

Laureate’s Bioprocessing Facility at Princeton, NJ to be Expanded Princeton, NJ – January 3, 2006 – Laureate Pharma, Inc., a wholly-owned subsidiary of Safeguard Scientifics, Inc. (NYSE: SFE), announced today that it had completed the previously announced sale of its Totowa, NJ operations to Discovery Laboratories, Inc. (NASDAQ: DSCO) for $16.0 million in cash. Laureate Pharma, a provider of bioprocessing services to pharmaceutical and biopharmaceutical companies, conducts its principal operations…

Laureate Biopharma Appoints Ann M. Daus, Ph.D. Vice President, Quality

– Leads implementation of Laureate’s strategic quality plan – PRINCETON, N.J., March 16, 2011 — Laureate Biopharmaceutical Services, Inc., a full-service biopharmaceutical contract development and manufacturing organization, today announced the appointment of Ann M. Daus, Ph.D, as Vice President, Quality. Dr. Daus will lead the implementation of Laureate’s strategic quality plan, recruit new leaders to supplement the quality management team, lead the strategic expansion of testing services and improve companywide…

Laureate Pharma Honored as Emerging Life Sciences Company of the Year

Laureate recognized for its business growth, leadership team and service innovation by the Eastern Technology Council Princeton, NJ, November 20, 2008: Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced that it has been named the “Emerging Life Science Company of the Year” by The Eastern Technology Council, the largest technology and life sciences trade association in the greater Philadelphia, PA region. The company was honored…

Laureate Pharma Announces Manufacturing Agreement with Alopexx Pharmaceuticals, LLC

Laureate To Manufacture Alopexx’s Product Candidate Princeton, NJ, April 10, 2008: Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced that it has entered into a cGMP contract manufacturing agreement with Alopexx Pharmaceuticals, LLC. According to the agreement, Laureate will produce Alopexx’s mAb F598 antibody under cGMP conditions. This antibody is planned for use in clinical trials, and later for commercial production for the treatment and…

Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody

Laureate to Manufacture ARIUS’ Product Candidate Trop-2 Signal Transduction Antibody Princeton, NJ, January 31, 2008: Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced that it has entered into a cGMP contract manufacturing agreement with ARIUS Research, Inc., a biotechnology company focused on discovering and developing the next wave of antibody therapeutics to treat cancer and other diseases, for its Trop-2 Signal Transduction Antibody Program. Laureate…

LAUREATE PHARMA ANNOUNCES AGREEMENT WITH TRUBION PHARMACEUTICALS

LAUREATE TO MANUFACTURE TRUBION’S TRU-016 PRODUCT CANDIDATE Princeton, NJ, January 30, 2007: Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced it has entered into an agreement to produce Trubion Pharmaceuticals, Inc.’s TRU-016, a novel protein for the treatment of non-Hodgkin’s lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Terms of the manufacturing agreement were not disclosed. Trubion’s TRU-016 program targets CD37, an antigen present on B…